Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma (Q28185284)

10

object named as

Eleftherios P Diamandis

0 references

Andreas Scorilas

object named as

Andreas Scorilas

9

0 references

Dionyssios Katsaros

11

object named as

Dionyssios Katsaros

0 references

author name string

Carla A Borgoño

1

0 references

Stefano Fracchioli

2

0 references

George M Yousef

3

0 references

Irene A Rigault de la Longrais

4

0 references

Liu-Ying Luo

5

0 references

Antoninus Soosaipillai

6

0 references

Manuela Puopolo

7

0 references

Linda Grass

International Journal of Cancer

8

0 references

language of work or name

English

0 references

publication date

10 September 2003

0 references

published in

0 references

volume

106

0 references

issue

4

0 references

page(s)

605-10

0 references

cites work

Cancer statistics, 2002

1 reference

Estimates of the worldwide incidence of 25 major cancers in 1990.

21 January 2018

1 reference

Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection

21 January 2018

1 reference

The inhibins and ovarian cancer

21 January 2018

1 reference

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology

21 January 2018

1 reference

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

21 January 2018

1 reference

Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer

21 January 2018

1 reference

Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue

21 January 2018

1 reference

Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues

21 January 2018

1 reference

KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.

21 January 2018

1 reference

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

21 January 2018

1 reference

Prostate-specific Antigen: Its Usefulness in Clinical Medicine

21 January 2018

1 reference

Human kallikrein 10: a novel tumor marker for ovarian carcinoma?

21 January 2018

1 reference

Human tissue kallikrein gene family: a rich source of novel disease biomarkers

21 January 2018

1 reference

cDNA cloning and expression of a novel serine protease, TLSP

21 January 2018

1 reference

Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family

21 January 2018

1 reference

Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates

21 January 2018

1 reference

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.

21 January 2018

1 reference

Increased expression of protease M in ovarian tumors.

21 January 2018

1 reference

Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention

21 January 2018

1 reference

Estrogen action in human ovarian cancer

21 January 2018

1 reference

Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses

21 January 2018

1 reference

Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview

21 January 2018

1 reference

Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin

21 January 2018

1 reference

Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells

21 January 2018

1 reference

Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma

21 January 2018

1 reference

Preoperative serum concentration of hCGbeta as a prognostic factor in ovarian cancer

21 January 2018

1 reference

The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer

21 January 2018

1 reference

The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis

21 January 2018

1 reference

Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses

21 January 2018

1 reference

The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells

21 January 2018

1 reference

Differential expression of trypsin in human ovarian carcinomas and low-malignant-potential tumors

21 January 2018

1 reference

The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines

21 January 2018

1 reference

Estradiol increases the production of alpha 1-antichymotrypsin in MCF7 and T47D human breast cancer cell lines

21 January 2018

1 reference

Two types of plasminogen activators secreted by MCP-7 cells

21 January 2018

1 reference